Abstract
The debate on sharing clinical trial data has been dominated by individual patient data. Tammy Hoffmann and colleagues argue that, although patient level data are important, a focus on the other simpler elements of trial transparency should be the first priority
Original language | English |
---|---|
Article number | j2782 |
Journal | BMJ (Online) |
Volume | 357 |
DOIs | |
Publication status | Published - 2017 |